Jyong Biotech Ltd. Ordinary Shares is a publicly traded company trading on NASDAQ, led by CEO Fu-Feng Kuo, with a market cap of $198.9M.
Common questions about Jyong Biotech Ltd. Ordinary Shares
Jyong Biotech Ltd. Ordinary Shares is scheduled to report earnings for Q1 2026 on May 19, 2026.
We use cookies for analytics. See our Privacy and Cookie Policy.